Perhaps patent law should be stronger in business sectors where there are, as Alex Tabarrok explains, high ???innovation-to-imitation costs??? such as pharmaceuticals and weaker where costs are lower, such as software.(Tabarrok gives the example of some miracle drug versus one-click shopping.) But given the tendency of business to lobby for ever-stronger patents, there is a case for outright aboli